Abstract
Background
With the onset of the COVID pandemic the use of electronic tools, including telehealth, increased out of necessity.
Objectives
The goal of this scoping review was to identify perceptions of benefits and limitations of the use of telehealth among cancer patients and their family caregivers. Eligibility-Criteria: This study reviewed articles from PubMed, EBSCO, and Google Scholar using search terms related to oncology and telehealth. Charting Methods: 39 articles were included and categorized as benefits or limitations of telehealth.
Results
All studies included patient perceptions while only three studies included caregivers. Benefit themes included (1) Convenience, (2) Savings, (3) Access to Care, (4) Work or Career, (5) Caregiver Inclusion and Perspective, and (6) Other. Limitation themes included (1) Disruption to Care Experience or Patient-Provider Relationship, (2) Need for Physical Examination, (3) Communication Challenges, and (4) Technology-Related Issues. Non-Hispanic White patients were the most prominent racial or ethnic group in the studies while six studies included a high percentage of Black patients.
Conclusions
Findings suggest that a hybrid approach might be best depending on the care needed while also benefit from cost-savings and convenience when feasible. Future research must consider the caregiver perspective more intentionally in understanding experiences of telehealth given implications for work. Additional research is also needed to develop strategies to address use differences according to demographics or due to technology barriers.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
1 Introduction
Prior to 2020, the U.S. population was slowly engaging more in the digital health, including electronic health records (EHRs) and patient portals. EHRs have been increasingly integrated into the clinical environment and used by patients over the past several years. Nearly 40% of U.S. adults in 2020 reported using their patient portal at least once over the past 12-months [1]. This usage is compared to 28.2% in 2017 and 27% in 2014 [1]. This, pre-COVID, uptake of digital health was due largely to the implementation of policies that incentivized use by health systems or clinics. As summarized by Johnson and colleagues, the 21st Century Cures Act and federal rulemaking sought to increase the access, exchange, and use of electronic health information by patients and their caregivers [2].
COVID-19 then further advanced virtual care and telehealth use broadly [3, 4]. As well known, COVID-19 required the use of telehealth to safeguard patients and health professionals. Now, since the onset of COVID, in which telehealth was a necessity, policies have further advanced to embrace virtual options for patients and families. For example, Medicare now reimburses for select services, particularly behavioral health services, while states have instituted policies (e.g., licensure) that allow for specific rights within a given jurisdiction [5]. Though still not universal in the U.S. population, access to telehealth has increased.
Oncology was no different than most care disciplines in needing to accommodate practice during COVID-19 and in the years since. With over 1.9 million Americans expected to receive a cancer diagnosis in 2023 [6], understanding and addressing the needs of patients and their caregivers with respect to uptake is essential. In recent years, the American Society of Clinical Oncology (ASCO) provided guidance anticipating increasing use [7]. The physical, psychological, and financial impact of cancer on patients is often profound and extends to adversely impact those who are supporting a patient (i.e., caregivers). Caregivers provide patients with logistical, emotional, and nursing-related support [8,9,10,11]. Thus, telehealth might provide an opportunity to increase access and better engage caregivers and provide them with better support.
By exploring the oncology literature about use of telehealth, we can better understand how such care might be used to support the care experience for patients and their family caregivers. This analysis might be particularly important given the known areas of strain, especially for populations – patients and caregivers alike – vulnerable to poor physical and emotional deficits and glaring disparities. Indeed, access to care, financial toxicity, and career impact are examples of known strains for patients and caregivers and of which there are significant disparities [12]. To date, literature reviews on telehealth use exist but are not specific to the context of the US, do not focus specifically on perceived benefits and limitations of telehealth for cancer patients and their family caregivers, or lack description of review methodology [13,14,15].
The goal of this scoping review was to identify studies pertaining to the use of telehealth among persons with cancer (i.e., cancer patients) and their caregivers to synthesize benefits and limitations with use. Interactions with providers is a necessity when diagnosed with cancer and availability through telehealth is increasing and might offer greater access to ongoing care, but only if barriers and limitations among all patients and caregivers—who are regularly part of care communication [8] – are addressed.
2 Methods and procedures
2.1 Study design
This study was a scoping review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The process involved identifying relevant research articles, screening the articles for eligibility, and synthesizing study data and findings from the articles deemed eligible [16].
2.2 Eligibility criteria
Inclusion criteria for articles included: (1) studies involving use of telehealth/telemedicine (herein after used “telehealth”); (2) findings related to use and experiences among a cancer patient and/or their caregiver; (3) studies conducted in the United States; and (4) studies conducted between March 2020 to July 2023. Articles were excluded if they did not involve telehealth use; cancer patient or caregiver perspective of use of telehealth; or were studies not conducted in the United States or between March 2020 and July 2023. The review was limited to the US due to the specifics of the US healthcare system and varied access to telehealth globally. The focus on US studies allowed for all studies to be conducted generally within a similar context or policy ecosystem. The years for the scoping review were also limited to those from the time point of COVID going forward to manuscript development.
2.3 Procedures
The articles for this scoping literature review were identified by searching the PubMed, EBSCO, and Google Scholar databases. Due to the extensive searching mechanism of Google Scholar, the first 200 articles retrieved were included as identified articles, as previously found to be best practice [17]. The search terms included: (patient OR care recipient) AND (caregiver OR family caregiver OR informal caregiver) AND (telehealth OR telemedicine) AND (oncology OR cancer). The date range filter option was used with each database to include articles published between March 2020 and July 2023 (when the search was conducted). The articles identified using the PubMed, EBSCO, and Google Scholar databases were exported to EndNote into separate libraries, and, using the EndNote functionality, removed duplicate articles.
All articles were screened by title, date, and abstract to assess initial eligibility. Articles that seemed to meet eligibility following the initial screening were reviewed in full-text and excluded if found to be ineligible upon in-depth review. The full-text articles were screened independently by two reviewers. Secondary review included confirmation of article eligibility according to inclusion and exclusion criteria in addition to confirmation of findings abstracted from each article.
2.4 Analysis
Data from each article was abstracted into a data table (see Table 1). Abstracted data includes study purpose, cancer type, study design and measurement, sample descriptions including patient and/or caregiver’s demographics (e.g., age, gender, race, and ethnicity), and primary outcomes related to telehealth use. Article findings were synthesized according to perceived benefits and limitations of telehealth, which were further categorized into themes as described below.
3 Results
The initial article search identified 1,005 articles for initial review. After removing duplicates and conducting the initial screening and full-text review, 39 articles were identified as eligible for this scoping review. Figure 1 outlines the PRISMA article identification process in detail. Most of the eligible articles involved quantitative analyses, including analysis of patient satisfaction surveys and/or patient and healthcare provider surveys [16, 18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36]. Other studies were qualitative, including only interviews or focus groups [37,38,39,40,41,42,43,44,45,46] or involved a mixed-methods approach [27, 47,48,49]. Varied oncologic specialties are represented in the included articles, including breast [24, 27, 39, 43], gynecologic [31, 36, 42], hematologic/oncologic[38, 45, 46], neuro-oncology[25], liver [47], prostate [18], lung [41], and a combination of breast and gynecologic [35]. Additional characteristics are provided in Table 1, including the age, gender and race or ethnicity of the samples when reported. All studies included patient perceptions while three studies included caregiver perceptions. The participants in most studies were predominantly non-Hispanic White and at a proportion higher than the general United States population (58.9%), while six studies [20, 24, 26, 34, 44, 50] had representation of Black participants at the ratio higher than that in the U.S. population (13.6%) [51]. Table 1 outlines the characteristics of each article and outcomes related to telehealth use or perceptions. The results are categorized below according to the patient and/or caregivers’ perceived benefits and limitations of telehealth, along with specific subthemes for benefits and limitations for added detail.
3.1 Benefits of telehealth
Benefits of telehealth as reported in the studies most often related to a (1) Convenience, (2) Savings, (3) Access to Care, (4) Work or Career, (5) Caregiver Inclusion and Perspective, or (6) Other given the array of perceived benefits. These themes are described below per findings.
3.1.1 Convenience
Across several studies, 28–87.4% of patients perceived telehealth to be “convenient” as measured as a yes or no [21, 26, 34, 38, 39, 44, 46, 49, 50, 52, 53]. However, differences were noted according to sociodemographic factors. For example, when reporting on telehealth cancer genetic counseling during COVID-19, patients with lower education levels, older age (> 70 years of age), and male sex were less relieved or grateful for telehealth visits [53]. Moreover, Darcourt and colleagues reported that, though a high percentage of patients were satisfied with telehealth, the patients who declined participation in video telehealth visits for cancer care during the early months of COVID were significantly older, lived in significantly lower-income areas, and were significantly less likely to have commercial insurance than patients who participated [54].
3.1.2 Savings
The specific savings aspects of telehealth included (1) time savings [18, 21, 23, 31, 34, 35, 38, 41, 42], (2) travel savings [18, 20, 23, 25, 29, 31, 39, 41, 43], and (3) cost savings [18, 26, 38, 42, 43, 46]. For example, in three studies the time, travel, and cost savings were transportation-specific, such as reducing and/or eliminating time spent in a vehicle for in-person appointments [42], reducing mileage traveled by participants [39], and saving money on both parking and gas [38, 42]. Other savings-related benefits included reduced overall time for appointments due to not having clinic wait times that are commonly associated with in-person appointments [42] and savings on co-pays due to the virtual nature of the telehealth appointment [43].
3.1.3 Access to care
Several studies pertained to improved access to care [20, 26, 30, 35, 39, 40]. For example, one study reporting the perception that one could access care sooner via telehealth compared to an in-person appointment [55], while another study reported the benefit of engaging in an accessable manner among patients with disabilites [39]. Two studies reported that telehealth expanded access to other services, such as supportive cancer care services (that otherwise were inconvenient or inefficient to attend) [40] or to other health professionals, like social care professionals [35].
3.1.4 Work or career
Six of the articles included a theme of convenience of telehealth and work schedule [26, 29, 38, 40, 42, 49]. Studies described in five of the six articles specified that not having to take time away or off from work was an advantage of telehealth appointments [26, 29, 38, 40, 49], two studies specifically identifying the decrease in travel/parking time as a means of saving time as related to work impact [29, 38].
3.1.5 Caregiver inclusion and perspective
Two studies noted the benefit of the ability to include family members [43, 55]. Three articles included caregivers in the samples [22, 45, 46]. Two of these studies included the patient and caregivers’ perspective together [22, 46] with one study only having one caregiver included [46], while in the additional, third, study the caregiver perspective was reported upon separately [45]. In this study, the caregivers for pediatric oncology patients reported the impact of the COVID-19 pandemic on their general daily life and children’s medical care, with COVID-19 exposure being the main concern. Caregivers identified telemedicine as a means of allowing continued communication with their children’s healthcare providers without the potential of COVID-19 exposure associated with in-person appointments [45]. An additional study, including the perspectives of both adult survivors of pediatric cancer and their caregivers, explored difficulties and satisfaction with telehealth. Most participants reported that telehealth is an effective way to obtain medical care. When compared to in-person visits, participants reported telehealth visits were better regarding travel time, convenience, and wait time, whereas in-person visits were better regarding connection with the medical provider and provider’s ability to understand the clinical issue [22].
3.1.6 Other
Other reported advantages of telehealth visits include the reduced risk of infection [25, 38, 42, 44, 45, 49, 55], the opportunity to be in a comfortable setting for a visit [43, 50, 55], and a decrease in stress related to amount of distance for in-person visits – especially for rural patients coming from a great distance [39, 46].
3.2 Limitations with telehealth
Several limitations of telehealth were also reported by participants and are categorized as follows: (1) Disruption to Care Experience or Patient-Provider Relationship, (2) Need for Physical Examination, (3) Communication Challenges, and (4) Technology-Related Issues.
3.2.1 Disruption to care experience or patient-provider relationship
Participants noted that the initial transition from in-person to virtual appointments was disruptive to their care and patient-provider relationship due to decreased face-to-face interactions with health professionals [21] and a perceived inability to ask questions that would normally occur during in-person appointments [22]. Some participants agreed that they did not find communicating with a medical provider during a telehealth appointment as satisfactory as compared to in-person [21, 38, 49].
3.2.2 Need for physical examination
Participants also noted the inability of healthcare providers to conduct a physical examination on patients during a telehealth appointment [29, 31, 45, 49, 55]. Specifically for survivors of cancer in one study, 58.8% (n = 110) considered a physical examination critical to detecting recurrence [31]. Additionally, participants in three articles reported missing the physical presence and/or touch of a medical provider that is received during an in-person appointment [21, 38, 40]. In the study conducted by Nguyen-Grozavu and colleagues [43] examining the perspectives of Hispanic breast cancer patients, it was noted that participants found telehealth less effective in building trust as compared to in-person visits. Similarly, a common theme among participants of the included articles was the preference for hybrid oncology care, including both in-person and virtual appointments. Participants reported that it was important to have their initial appointment conducted in-person to establish care and build rapport with their provider [36, 38, 55]. As demonstrated by the participants of the study conducted by Harrington et al. (2023) [55], 55% reported they would not use telehealth to establish care. Additionally, patients reported that appointments focusing on imaging or lab results [20, 37], asking their provider questions [21, 36, 37], and participating in support and/or social groups were more appropriate for telehealth appointments [20, 37].
3.2.3 Communication challenges
Primary challenges were a need for an interpreter [43, 49] or issues related to privacy of communication or confidentiality [26, 49]. One study also noted preferring in-person because of the virtual lacking the important non-verbal communication and interaction [50].
3.2.4 Technology-related issues
Various technology-related issues were noted, including those related to systems [29] such as software malfunction [38], difficulty navigating or using a system [22, 40, 41], difficulty understanding instructions on accessing telemedicine platform and unstable connections or poor Internet [23, 27, 38, 49, 56], and lack of access to equipment, devices, or Internet [26]. Related is also the concern of telehealth literacy [46]. In one study, technology problems were reported to be addressed by moving to audio-only calls [50].
4 Discussion
Cancer remains a significant population health concern. It was expected that over 1.9 million individuals in the U.S. in 2023 were to be informed of a cancer diagnosis, while an increasing number of Americans, 26 million by 2040, are expected to be cancer survivors [6, 57]. People are also living longer with cancer and many 5-year survival rates are higher for a greater number of cancers [57]. Interactions with providers when diagnosed with cancer is a necessity, and access to providers through telehealth is increasing and might improve access and sustainability to ongoing care, but only if barriers and limitations among all patients and caregivers—who are regularly part of care communication [8]—are addressed.
Findings suggest that for patients and caregivers there are both benefit and limitations of utilizing telehealth for oncology care. However, most evidence identified was at the patient-level and highlights a major gap in information about family caregiver perceptions and preferences. Our findings (predominantly patient-based) indicate common benefits across oncology settings, including convenience and time, travel, and cost savings. Findings also suggest that an all-virtual approach in oncology is not feasible nor preferred as hands-on examinations are necessary, including for ongoing survivorship care and prevention. Thus, a hybrid approach is likely best going forward. Ongoing research should continue to explore the preferences and needs of patients, caregivers, clinicians and health systems with respect to the use of telehealth in oncology.
Though limited in the number of studies that engaged caregivers, these findings suggest there are perceived benefit of involvement. Patients report that telehealth increases the ability for the caregiver to be involved. Caregivers are well established as vital to patient care; yet career impact and burden is common and is a significant financial challenge to them [8]. Replacing onsite visits with virtual appointments when feasible is a potential option to improve caregiver engagement more broadly and reduce career and related emotional strain. In 2021 Blue Cross Blue Shield reported the direct and indirect impact of caring as $264 billion and encompassing 51 million Americans [58]. This included work impacts such as disruption in hours or retiring early or quitting [58, 59]. Future research must more intentionally consider the caregiver perspective in understanding experiences of telehealth, particularly as related to employment and career maintenance.
Furthermore, findings for studies that had greater racial and ethnic diversity reported generally similar benefits and concerns among participants compared to studies with a less diverse population. However, differences were evident according to technology-based barriers. Addressing differences in access and overcoming barriers to use is vital given that alarming disparities in cancer outcomes continue to exist by race and ethnicity for certain cancers [60, 61]. Indeed, African American or Black individuals have a disproportionate cancer burden, including the highest mortality and the lowest survival of any racial or ethnic group for most cancers. Black patients continue to be less likely to be diagnosed with stage I disease than White patients for most cancers, with some of the largest disparities for female breast (53% vs 68%) and endometrial (59% vs 73%) [60]. An ACS Survivorship report calls upon evidenced-based strategies and equitable access to available resources to mitigate disparities [57]. If barriers are addressed, telehealth might have the potential to improve access to care and outcomes.
Though non-Hispanic White patients were most prominent racial or ethnic group in the studies, six studies included a high percentage of Black patients. The findings were not specific to race or ethnicity or other sociodemographic variables, but findings for each of these studied showed similar benefit and concerns compared to studies with less diverse populations. This included findings about the appropriate type of service for telehealth (e.g., affirming survivorship care), the use of telephone for appointments, greater convenience and affordability (less indirect costs) [20, 24, 26, 34, 50]. However, in one of these studies with greater racial and ethnic diversity of sample, those with higher household income had higher odds of use of telemedicine than those with lower income [24]. Similarly, in another study high barriers included barriers to the Internet or devices or not wanting to be on video [26]. Moreover, these findings mirror research internationally in which, in one study, the proportion of telehealth visits conducted among Black patients was found to be significantly lower compared with White patients and Black participants were more likely to self-report lack of Internet access [62]. These findings suggests the need to ensure equitable access for such services, including policies that promote access to Internet, or the removal of barriers to use or uncertainty.
In addition to differences according to race and ethnicity, additional differences are also noted, including according to age, income, low health digital literacy, and limited English proficiency [63]. An international study by Loree and colleagues found that older adults (≥ 50 years of age) were less likely to be satisfied with virtual oncology appointments [64]. This review also showed that challenges with telehealth in terms of communication were evident, such as the need for interpreter services. Future research should consider additional challenges for patients who might have other communication-related challenges that were not noted in these studies, such as persons with vision, hearing, or cognitive impairments.
5 Limitations
It is possible that not all eligible articles were included. Articles were only included if they were from the U.S., but it is possible that there is well-documented evidence from other countries regarding telehealth use in oncology. Despite these limitations, this scoping review is an important review to begin to establish understanding of preferences of patients and caregivers for further study and benchmarking. This is especially important given the identified gap in caregivers’ perceptions.
6 Conclusion
This scoping review identified ways that telehealth is beneficial for patients but might also benefit caregivers. These benefits pertain most often to time and cost savings. Concerns most often pertain to limitations as compared to onsite visits and the ability to fully examine patients or engage with them as well as technology-related issues. Future research must specifically assess perceptions among caregivers and assess use as related to disrupting disparities in access and outcomes in oncology.
Data availability
No datasets were generated or analysed during the current study.
References
Institute, N.C., Health Information National Trends Survey Brief 45. 2021.
Johnson, C., C. Richwine, and V. Patel, Individuals’ Access and Use of Patient Portals and Smartphone Health Apps, 2020. 2021, Office of the National Coordinator for Health Information Technology.
Group, C.E.F.V.C.W., Virtual Care in Canada: Lexicon. 2020.
Deshpande N, et al. eHealth literacy and patient portal use and attitudes: cross-sectional observational study. JMIR Hum Factors. 2023;10: e40105.
Services, D.o.H.a.H. Telehealt.hhs.gov. 2024. https://telehealth.hhs.gov/.
Siegel RL, et al. Cancer statistics, 2023. CA Cancer J Clin. 2022;73(1):17–48.
Zon RT, et al. Telehealth in oncology: ASCO standards and practice recommendations. JCO Oncol Pract. 2021;17(9):546–64.
Hunt, G.H., et al., Cancer caregiving in the U.S.: An intense, episodic, and challenging care experience. 2016, National Alliance for Caregiving.
Kim Y, Schulz R. Family caregivers’ strains: comparative analysis of cancer caregiving with dementia, diabetes, and frail elderly caregiving. J Aging Health. 2008;20(5):483–503.
McPherson, C.J., et al. A qualitative investigation of the roles and perspectives of older patients with advanced cancer and their family caregivers in managing pain in the home. BMC Palliat Care, 2014.
IOM, Retooling for an aging America: Building the health care workforce. Washington The National. DC: Academies Press; 2008.
Alfano CM, et al. Equitably improving outcomes for cancer survivors and supporting caregivers: a blueprint for care delivery, research, education, and policy. CA Cancer J Clin. 2019;69(1):35–49.
Shaffer KM, et al. Digital health and telehealth in cancer care: a scoping review of reviews. Lancet Digit Health. 2023;5(5):e316–27.
Toni E, Ayatollahi H. An insight into the use of telemedicine technology for cancer patients during the Covid-19 pandemic: a scoping review. BMC Med Inform Decis Mak. 2024;24(1):104.
West HJ, Barzi A, Wong D. Telemedicine in cancer care beyond the COVID-19 pandemic: oncology 2.0? Curr Oncol Rep. 2022;24(12):1843–50.
Paige SR, et al. Cancer patients’ satisfaction with telehealth during the COVID-19 pandemic. PLoS ONE. 2022;17(6): e0268913.
Haddaway NR, et al. The role of google scholar in evidence reviews and its applicability to grey literature searching. PLoS ONE. 2015;10(9): e0138237.
Ahmed ME, et al. Patient satisfaction of telemedicine visits in an advanced prostate cancer clinic during the COVID-19 pandemic. Mayo Clin Proc Innov Qual Outcomes. 2021;5(3):689–92.
Alexander K, et al. Development and implementation of an interdisciplinary telemedicine clinic for older patients with cancer-Preliminary data. J Am Geriatr Soc. 2023;71(5):1638–49.
Arem H, et al. Cancer provider and survivor experiences with telehealth during the COVID-19 pandemic. JCO Oncol Pract. 2022;18(4):e452–61.
Bellizzi KM, et al. Disruption in cancer care during early survivorship due to the covid-19 pandemic and patient satisfaction with telemedicine. Support Care Cancer. 2023;31(5):291.
Cacciotti C, et al. Pediatric central nervous system tumor survivor and caregiver experiences with multidisciplinary telehealth. J Neurooncol. 2023;162(1):191–8.
Chang PJ, et al. Patient and provider-reported satisfaction of cancer rehabilitation telemedicine visits during the COVID-19 pandemic. Pm r. 2021;13(12):1362–8.
Du S, et al. Patient-reported experiences of breast cancer screening, diagnosis, and treatment delay, and telemedicine adoption during COVID-19. Curr Oncol. 2022;29(8):5919–32.
Gardner MM, et al. Cancer, cognition, and COVID: delivering direct-to-home teleneuropsychology services to neuro-oncology patients. Neurooncol Pract. 2021;8(4):485–96.
Hassan AM, et al. Determinants of telemedicine adoption among financially distressed patients with cancer during the COVID-19 pandemic: insights from a nationwide study. Support Care Cancer. 2022;30(9):7665–78.
Johnson BA, et al. The New Normal? patient satisfaction and usability of telemedicine in breast cancer care. Ann Surg Oncol. 2021;28(10):5668–76.
Liu JKC, et al. Patient satisfaction and cost savings analysis of the telemedicine program within a neuro-oncology department. J Neurooncol. 2022;160(2):517–25.
Mojdehbakhsh RP, et al. The long game: telemedicine patient satisfaction metrics and methods of recurrence detection for gynecologic cancer patients throughout the initial year of the COVID-19 pandemic. Gynecol Oncol Rep. 2022;42: 101037.
Patel KB, et al. Telemedicine adoption in an NCI-designated cancer center during the COVID-19 pandemic: a report on patient experience of care. J Natl Compr Canc Netw. 2023;21(5):496-502.e6.
Quam N, et al. Perception of telehealth during the COVID-19 pandemic among survivors of gynecologic cancer. Oncologist. 2022;27(6):512–5.
Rodriguez GM, et al. The impact of COVID-19 on patients with cancer: a national study of patient experiences. Am J Clin Oncol. 2021;44(11):580–7.
Shaverdian N, et al. Impact of telemedicine on patient satisfaction and perceptions of care quality in radiation oncology. J Natl Compr Canc Netw. 2021;19(10):1174–80.
Wehrle CJ, et al. Patient and physician attitudes toward telemedicine in cancer clinics following the COVID-19 Pandemic. JCO Clin Cancer Inform. 2021;5:394–400.
Zimmerman BS, et al. Patient perception of telehealth services for breast and gynecologic oncology care during the COVID-19 pandemic: a single center survey-based study. J Breast Cancer. 2020;23(5):542–52.
Wong J, et al. Telemedicine and gynecologic oncology: caring for patients remotely during a global pandemic. AJOG Glob Rep. 2022;2(4): 100124.
Arthur EK, et al. Older cancer survivors’ perspectives and use of telehealth in their cancer survivorship care in the United States: A ResearchMatch® sample. J Geriatr Oncol. 2022;13(8):1223–9.
Boucher AA, et al. Adult hematology/oncology patient perspectives on telemedicine highlight areas of focus for future hybrid care models. Telemed J E Health. 2023;29(5):708–16.
Buse CR, et al. Perspectives of older women with early breast cancer on telemedicine during post-primary treatment. Support Care Cancer. 2022;30(12):9859–68.
Evered J, et al. The impact and implications of virtual supportive cancer care during the COVID-19 pandemic: integrating patient and clinician perspectives. Support Care Cancer. 2022;30(12):9945–52.
Ha DM, et al. Lung cancer survivors’ views on telerehabilitation following curative intent therapy: a formative qualitative study. BMJ Open. 2023;13(6): e073251.
Kraus EJ, Nicosia B, Shalowitz DI. A qualitative study of patients’ attitudes towards telemedicine for gynecologic cancer care. Gynecol Oncol. 2022;165(1):155–9.
Nguyen-Grozavu F, Ko E, A. Valadez Galindo, gauging the changing landscape: telehealth perceptions among hispanic females with breast cancer. Int J Environ Res Public Health. 2023;20(3):1713.
Rodriguez GM, Kumar D, Patel MI. “I have constant fear”: a national qualitative study on the impact of COVID-19 on Cancer care and potential solutions to improve the cancer care experience during the COVID-19 pandemic. JCO Oncol Pract. 2023;19(7):427–34.
Steinberg DM, et al. I’ve weathered really horrible storms long before this…": the experiences of parents caring for children with hematological and oncological conditions during the early months of the COVID-19 pandemic in the U.S. J Clin Psychol Med Settings. 2021;28(4):720–7.
Woodard A, Eche IJ, Leak Bryant A. Telehealth use in rural north carolina counties: perceptions among patients with acute myeloid leukemia. Clin J Oncol Nurs. 2022;26(5):569–73.
Choi DT, et al. Using telemedicine to facilitate patient communication and treatment decision-making following multidisciplinary tumor board review for patients with hepatocellular carcinoma. J Gastrointest Cancer. 2023;54(2):623–31.
Mojdehbakhsh RP, et al. A quality improvement pathway to rapidly increase telemedicine services in a gynecologic oncology clinic during the COVID-19 pandemic with patient satisfaction scores and environmental impact. Gynecol Oncol Rep. 2021;36: 100708.
Ludwigson A, et al. Patient perceptions of changes in breast cancer care and well-being during COVID-19: a mixed methods study. Ann Surg Oncol. 2022;29(3):1649–57.
Tam S, et al. The perceived usability of virtual visits among black adults’ receiving oncology care: a qualitative analysis. Oncologist. 2024;29(2):e237–47.
Bureau, U.S.C. Quick Facts: United States. 2024. https://www.census.gov/quickfacts/fact/table/US/RHI225222#RHI225222.
Aghedo BO, et al. Telehealth adaptation for multidisciplinary colorectal cancer clinic during the COVID-19 pandemic. Cureus. 2021;13(9): e17848.
Breen KE, et al. Factors influencing patient preferences for telehealth cancer genetic counseling during the COVID-19 pandemic. JCO Oncol Pract. 2022;18(4):e462–71.
Darcourt JG, et al. Analysis of the implementation of telehealth visits for care of patients with cancer in Houston during the COVID-19 pandemic. JCO Oncol Pract. 2021;17(1):e36–43.
Harrington CA, et al. Translating telemedicine to thoracic surgical oncological care: performance analysis and patient perceptions during the COVID-19 pandemic. Ann Surg. 2023;278(1):e179–83.
Fassas S, et al. Telemedicine for head and neck cancer surveillance in the COVID-19 era: Promise and pitfalls. Head Neck. 2021;43(6):1872–80.
Miller KD, et al. Cancer treatment and survivorship statistics, 2022. CA Cancer J Clin. 2022;72(5):409–36.
Shield, B.C.B., The Economic Impact of Caregiving. 2021.
NAC and AARP, Caregiving in the U.S. 2020 Report. 2020, National Alliance for Caregiving AARP
Giaquinto AN, et al. Cancer statistics for African American/Black People 2022. CA Cancer J Clin. 2022;72(3):202–29.
Islami F, et al. American Cancer Society’s report on the status of cancer disparities in the United States, 2021. CA Cancer J Clin. 2022;72(2):112–43.
Iasiello JA, et al. Racial differences in patient-reported access to telehealth: an important and unmeasured social determinant of health. JCO Oncol Pract. 2023;19(12):1215–23.
Dixit N, et al. Disparities in telehealth use: How should the supportive care community respond? Support Care Cancer. 2022;30(2):1007–10.
Loree JM, et al. Virtual oncology appointments during the initial Wave of the COVID-19 pandemic: an international survey of patient perspectives. Curr Oncol. 2021;28(1):671–7.
Funding
No funding was received to support this work.
Author information
Authors and Affiliations
Contributions
ML: conceptualization, methodology, data (article) analysis/synthesis, interpretation, manuscript writing; LR: data collection, data analysis, manuscript writing.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Longacre, M.L., Roche, L. Patient and family caregiver perceptions of telehealth in oncology in the US: a scoping review. Discov Med 1, 138 (2024). https://doi.org/10.1007/s44337-024-00126-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s44337-024-00126-3